Drugs of anesthesia, central nicotinic receptors and Parkinson's disease

Parkinsonism and Related Disorders

Volumn 10, Issue 3, 2004, Pages 189-190

  Fodale, V ^a   Pratico C ^a   Santamaria, L B ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; CISATRACURIUM; LAUDANOSINE; MUSCLE RELAXANT AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PANCURONIUM; PROPOFOL; VECURONIUM;

COGNITIVE DEFECT; DRUG DESIGN; DRUG EFFECT; GENERAL ANESTHESIA; HUMAN; IC 50; LETTER; MEMORY DISORDER; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 1342300590     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2003.11.004     Document Type: Letter

References (12)

1. Belluardo N., Mudo G., Blum M., Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav Brain Res. 113:2000;21-34.
2. Ryan R.E., Ross S.A., Drago J., Loiacono R.E. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br J Pharmacol. 132:(8):2001;1650-1656.
3. Nicholson G., Pereira A.C., Hall G.M. Parkinson's disease and anaesthesia. Br J Anaesth. 89:2002;904-916.
4. Fodale V., Santamaria L.B. Drugs of anaesthesia, central nicotinic receptors and post-operative cognitive dysfunction. Acta Anaesthesiol Scand. 47:(9):2003;1180.
5. Fodale V., Santamaria L.B. The inhibition of central nicotinic nAch receptors is the possible cause of prolonged cognitive impairment after anaesthesia. Anesth Analg. 97:(4):2003;1207.
6. Tassonyi E., Charpantier E., Muller D., Dumont L., Bertrand D. The role of nicotinic acetylcholine receptors in the mechanisms of anaesthesia. Brain Res Bull. 57:2002;133-150.
7. Fodale V., Santamaria L.B. Laudanosine, an atracurium and cisatracurium metabolite. Eur J Anaesthesiol. 19:(7):2002;466-473.
8. Tassonyi E., Fathi M., Hughes J., Chiodini F., Bertrand D., Muller D., Fuchs-Buder T. Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage. Acta Anaesthesiol Scand. 46:(11):2002;1236-1241.
9. Sugai Y., Sugai K., Hirata T., Okuda C., Miyazaki M. The interaction of pancuronium and vecuronium with cardiac muscarinic receptors. Acta Anaesthesiol Scand. 31:(3):1987;224-226.
10. Garland C.M., Foreman R.C., Chad J.E., Holden-Dye L., Walker R.J. The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms. Eur J Pharmacol. 357:(1):1998;83-92.
11. Fodale V., Santamaria L.B. The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite. Acta Anaesthesiol Scand. 47:(6):2003;780-781.
12. O'Neill M.J., Murray T.K., Lakics V., Visanji N.P., Duty S. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr Drug Target CNS Neurol Disord. 1:2002;399-411.